Clearwater Analytics Holdings, Inc. (CWAN)
NYSE: CWAN · Real-Time Price · USD
24.14
+0.01 (0.04%)
At close: Apr 28, 2026, 4:00 PM EDT
24.15
+0.01 (0.04%)
After-hours: Apr 28, 2026, 7:00 PM EDT

Clearwater Analytics Holdings Earnings Call Transcripts

Fiscal Year 2025

  • Status update

    The U.S. economy is projected to avoid recession in 2026, supported by resilient consumer spending and strong corporate profits, despite persistent inflation and a softening labor market. The Federal Reserve is expected to maintain a cautious, neutral policy stance as tariff impacts gradually reach consumers.

  • The company highlighted its expanded platform and market reach following recent acquisitions, driving a TAM increase to $23 billion and improved operational efficiency. Q3 saw strong margins and cash flow, with a focus on cross-sell, AI-driven margin gains, and a vision to become the industry standard for investment management data.

  • Strong financial performance and international growth were highlighted, with improved margins and cash conversion. The Enfusion acquisition is driving operational synergies and a unified platform strategy, while generative AI is delivering measurable margin gains and productivity improvements.

  • Q3 2025 saw 77% year-over-year revenue and ARR growth, with adjusted EBITDA margin rising to 34.5%. Gross revenue retention remained at 98%, and cross-sell bookings surged 70% year-over-year, driven by strong demand in alternatives and risk solutions.

  • Expanded from regional to global, integrating front-to-back solutions and doubling TAM through acquisitions and international growth. Focused on cross-sell, rapid synergy realization, and margin improvement, with accelerated deleveraging enabling share repurchases.

  • Investor Day 2025

    Management outlined a strategy to integrate recent acquisitions into a unified, cloud-native platform, driving operational efficiency, margin expansion, and industry transformation. Financial guidance was raised, with a focus on 20% revenue growth, 82% gross margins, and a $100M share buyback in 2026, all underpinned by GenAI innovation and disciplined execution.

  • Expanded capabilities through Enfusion and Beacon acquisitions have driven strong revenue and margin growth, with rapid synergy realization and early cross-sell wins. International expansion is accelerating, and a new pricing model is planned for 2026. Strategic vision will be detailed at the September Investor Day.

  • Record Q2 revenue and EBITDA growth driven by strong core and acquired business performance, rapid integration, and realization of $20M in synergies. Gross margin and retention metrics exceeded expectations, with robust guidance for continued growth and margin expansion.

  • The event detailed a technology-driven platform with a unique security master approach, high retention, and global reach. Recent acquisitions expand capabilities to front office and private assets, supporting a vision to become an industry utility. Financial discipline, margin improvement, and international growth are key priorities.

  • A unique SaaS provider leverages a single security master approach to deliver investment accounting, reporting, and risk solutions for asset managers and owners. Recent acquisitions expand capabilities and market reach, with a focus on cross-sell, AI-driven efficiency, and margin improvement.

  • Q1 2025 saw 23.5% revenue growth, record margins, and strong EBITDA, with major acquisitions positioning the company for integrated, cloud-native investment solutions. Guidance calls for 59–61% revenue growth in 2025, with synergies and cross-sell expected to accelerate future performance.

  • M&A Announcement

    The acquisitions of Beacon and Bistro, alongside Enfusion, aim to create a unified, cloud-native investment management platform spanning public and private assets. The deal is expected to drive operational efficiencies, expand the addressable market, and strengthen partnerships with industry leaders like Blackstone and PIMCO.

  • The discussion highlighted strong financial performance, with NRR and EBITDA margins exceeding targets, driven by high retention, pricing, and operational efficiency. The Enfusion acquisition is set to expand product capabilities, accelerate international growth, and support long-term strategic goals.

  • M&A Announcement

    The acquisition creates a unified, cloud-native platform for investment managers, expanding market reach, accelerating growth, and delivering significant cost synergies. The deal is expected to be accretive, with strong stakeholder support and a clear path to integration and margin expansion.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Powered by